ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VAL Valirx Plc

3.25
-0.20 (-5.80%)
Last Updated: 12:19:29
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Valirx Plc LSE:VAL London Ordinary Share GB00BLH13C52 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.20 -5.80% 3.25 3.20 3.30 3.45 3.25 3.45 495,968 12:19:29
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medical Laboratories 0 -2.37M -0.0262 -1.24 2.93M
Valirx Plc is listed in the Medical Laboratories sector of the London Stock Exchange with ticker VAL. The last closing price for Valirx was 3.45p. Over the last year, Valirx shares have traded in a share price range of 3.25p to 14.75p.

Valirx currently has 90,174,156 shares in issue. The market capitalisation of Valirx is £2.93 million. Valirx has a price to earnings ratio (PE ratio) of -1.24.

Valirx Share Discussion Threads

Showing 18751 to 18772 of 29350 messages
Chat Pages: Latest  754  753  752  751  750  749  748  747  746  745  744  743  Older
DateSubjectAuthorDiscuss
28/9/2020
08:02
Managed to bag another 30k at 64.75p on open and expecting £1 today
tburns
28/9/2020
08:01
Well I got that wrong !!I thought 80p okie lol
nico115
28/9/2020
07:56
Yeah, you're right mally.

- I'm gonna sell the lot in five minutes, and put the lot into BT.

- or the 3:45 at Newton Abbot.

801710245
28/9/2020
07:56
NOTE

Physiomics earlier this year signed a deal with the No.1 Prostate Cancer drug seller Astellas (Xtandi (enzalutamide) which sells $3bn p.a.)

Could they be a bridge for VAL to approach Astellas with regard to partnering VAL201 with Xtandi ?

the stigologist
28/9/2020
07:54
Not sure these results are so good long way to go for drug to come to market
mally6
28/9/2020
07:54
Gotta be a rerate for 100 Market Cap
shares188
28/9/2020
07:50
everyone had an early heads-up with the "it bloody works"
jusjusjus
28/9/2020
07:50
Suzy Dilly tweeting about the safety details and how they are helpful for the VAL drug pipeline...mentioning VAL301 & BC201

BC201 could be absolutely HUGE

fez
28/9/2020
07:49
remember SNG went from 35p to 190p (open/close) on that day, then went to 249p (close) 4 weeks later
jusjusjus
28/9/2020
07:48
Just goes to show the MM tactics of Friday, when the share price was driven 'sub-50p'. I had a feeling this would happen at some point at the start of Friday trading - but I'd have been lambasted if I'd suggested that at the time.

Who thinks the MMs may have had an early 'heads-up' - or am I being too much 'the conspiracy theorist'?

801710245
28/9/2020
07:46
If dddd can do it so can val. mcap is extremely low
justtrying1
28/9/2020
07:44
Not sure those results could have been better . Let us see where this goes in the first hour. But do not sell early guys. We will see wave 2 and 3 IMHO as the day develops and news is broadcast
stoneme
28/9/2020
07:43
I would be shocked if that low Look at dddd and SNG on data that didn't look as good as ours
nico115
28/9/2020
07:41
Excellent results guys
justtrying1
28/9/2020
07:38
Get in, what a great start to the week GLA
tburns
28/9/2020
07:34
First price 65:75...
nobbygnome
28/9/2020
07:34
Happy days guys. Great results. Huge blue day ahead. ?
dovey21
28/9/2020
07:32
And still only a MC of 30 million ...
bigman786
28/9/2020
07:30
What a future Val have now.
412069
28/9/2020
07:26
Wow now that's great data Excellent news for both patients and shareholders As George said "it bloody works "!!
nico115
28/9/2020
07:24
Great result for prostate cancer sufferers - potentially all men!

- 54% is excellent.

DDDD had a similar disease control rate of 42% with their recent MRx0518 / KEYTRUDA trial and the share price has virtually doubled.

fez
28/9/2020
07:22
Triple Whammy good news for PYC from VAL news

1. ORR of 50% is very good early result. Shows promise to get VAL201 licensed to a bigger player. Physiomics get FREE CARRIED UPSIDE and share of ANY licensing income (including upfronts, milestones, royalties)

2. Note VAL comment on 'optimal dosing strategies'. Given PYC helped them develop drug in first place Physiomics should get follow on work now to develop these 'optimal dosing strategies' given Physiomics are experts in Modelling and Simulation of exactly that

3. In considering Partnering Physiomics modelling expertise can also be used to model which drug will work best in combination with VAL201 and this can be used to narrow search for best partner.

the stigologist
Chat Pages: Latest  754  753  752  751  750  749  748  747  746  745  744  743  Older

Your Recent History

Delayed Upgrade Clock